RAD April 2022 Conference Abstracts and Posters
246 - Racial differences in the association of cytokine and chemokine expression with itch intensity in patients with moderate-to-severe atopic dermatitis
Olusola O. Oladipo PhD, Junwen Deng BA, Varsha Parthasarathy BS, Zachary Bordeaux BS, Matthew Taylor BA, Youkyung S. Roh BS, Melika Marani BS, Kevin Lee BS, Waleed Adawi MS, Anusha Kambala, Hannah L. Cornman, Thomas Pritchard MPH, Ali Alajmi MD, Martin P. Alphonse PhD, Shawn G. Kwatra MD
247 - Atopic Dermatitis in Adults: Experience of a tertiary care center
Foy VM, BA, Munayco Maldonado G, BA, Chiesa Fuxench ZC, MD MSCE
248 - Clinico-etiological profile of Atopic Dermatitis in North East India
Reena Lamba, Dr.
249 - Assessment of the validity of international classification of disease tenth revision codes for atopic dermatitis
Sneha Iyer, BS, Eric Sanfillipo, BS, Jonathan I. Silverberg, MD, PhD, MPH
250 - A Unique Botanical Extract Modulates Gene Expression Associated with Atopic Dermatitis in Human Keratinocytes
John Snowball, Heather Matheny, Julie Ashe, Scott Hartman, Teresa DiColandrea and Kevin J. Mills
251 - The Risk of Herpetic and Non-Herpetic Cutaneous Infections in Adult Patients with Atopic Dermatitis treated with oral Janus Kinase Inhibitors: a systematic review and meta-estimate of randomized clinical trial data
Eduardo A. Michelen-Gómez, MD; Zelma C. Chiesa Fuxench, MD MSCE
252 - Disease Control and Quality of Life: Efficacy Outcomes from the Phase 2b Trial of CBP-201 in Patients with Atopic Dermatitis (CBP-201-WW001)
Jonathan I. Silverberg, Bruce Strober, Emma Guttman-Yassky, Jinhua Xu, Eric Simpson, Pauline Li, Malinda Longphre, Raul Collazo, Zheng Wei, Selwyn Ho
253 - Efficacy and Safety of B244, A Live Topical Biotherapeutic, in Patients with Pruritus Associated with Mild to Moderate Atopic Dermatitis
Hyun Kim, Ioannis Gryllos, Connie Li, Daniel Brownell, Todd Krueger